Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Same-day discharge after TAVR | IVL & women | Chest tube-clearing device boosts outcomes after surgery

News You Need to Know Today
Same-day discharge after TAVR | IVL & women | Chest tube-clearing device boosts outcomes after surgery
Wednesday, May 21, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Same-day discharge after TAVR linked to positive outcomes

When low-risk patients undergo transfemoral TAVR, they may be able to go home without spending a single night at the hospital.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Same-day discharge after TAVR linked to positive outcomes

Share on Twitter Share on Facebook Share on Linkedin
When low-risk patients undergo transfemoral TAVR, they may be able to go home without spending a single night at the hospital.
READ MORE >

IVL delivers significant value for women, real-world data confirm

Researchers tracked data from nearly 400 women with complex CAD who underwent treatment with Shockwave Medical's intravascular lithotripsy technology prior to PCI.

READ MORE >
The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.
Share on Twitter Share on Facebook Share on Linkedin

IVL delivers significant value for women, real-world data confirm

Share on Twitter Share on Facebook Share on Linkedin
The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.
Researchers tracked data from nearly 400 women with complex CAD who underwent treatment with Shockwave Medical's intravascular lithotripsy technology prior to PCI.
READ MORE >

Chest tube-clearing device improves recovery, limits readmissions after heart surgery

“Conventional chest tubes are prone to clogging, which can hinder recovery,” one researcher explained. 

READ MORE >
The PleuraFlow Active Clearance Technology (ACT) System from ClearFlow
Share on Twitter Share on Facebook Share on Linkedin

Chest tube-clearing device improves recovery, limits readmissions after heart surgery

Share on Twitter Share on Facebook Share on Linkedin
The PleuraFlow Active Clearance Technology (ACT) System from ClearFlow
“Conventional chest tubes are prone to clogging, which can hinder recovery,” one researcher explained. 
READ MORE >

Featured Articles

Johnson & Johnson MedTech ordered to pay $147M for antitrust violations

The company told Cardiovascular Business it respectfully disagrees with the jury's decision and is evaluating all possible legal options going forward. The Association of Medical Device Reprocessors, meanwhile, celebrated the news.

READ MORE >
money court scale of justice ruling legal settlement
Share on Twitter Share on Facebook Share on Linkedin

Johnson & Johnson MedTech ordered to pay $147M for antitrust violations

Share on Twitter Share on Facebook Share on Linkedin
money court scale of justice ruling legal settlement
The company told Cardiovascular Business it respectfully disagrees with the jury's decision and is evaluating all possible legal options going forward. The Association of Medical Device Reprocessors, meanwhile, celebrated the news.
READ MORE >

2 out of 5 heart failure patients are not seeing a cardiologist

Even seeing a cardiologist once per year can help these patients elevate their long-term survival. Many stay home, however, missing out on potentially life-saving guidance and/or treatment.

READ MORE >
doctor patient elderly check up hospital
Share on Twitter Share on Facebook Share on Linkedin

2 out of 5 heart failure patients are not seeing a cardiologist

Share on Twitter Share on Facebook Share on Linkedin
doctor patient elderly check up hospital
Even seeing a cardiologist once per year can help these patients elevate their long-term survival. Many stay home, however, missing out on potentially life-saving guidance and/or treatment.
READ MORE >

Heart patients, stroke survivors may live longer if they stay active after hospital discharge

Some patients struggle to bounce back after being hospitalized, but too much sedentary behavior could cause their health to get even worse. The research teams behind two separate studies are highlighting the importance of staying active.

READ MORE >
walk exercise support family
Share on Twitter Share on Facebook Share on Linkedin

Heart patients, stroke survivors may live longer if they stay active after hospital discharge

Share on Twitter Share on Facebook Share on Linkedin
walk exercise support family
Some patients struggle to bounce back after being hospitalized, but too much sedentary behavior could cause their health to get even worse. The research teams behind two separate studies are highlighting the importance of staying active.
READ MORE >

In Case You Missed It

Answering key follow-up questions after the FDA approved TAVR in asymptomatic patients

The approval of certain TAVR valves to be used in asymptomatic patients is expected to make a significant impact on patient care going forward. 

READ MORE >
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
Share on Twitter Share on Facebook Share on Linkedin

Answering key follow-up questions after the FDA approved TAVR in asymptomatic patients

Share on Twitter Share on Facebook Share on Linkedin
A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]
The approval of certain TAVR valves to be used in asymptomatic patients is expected to make a significant impact on patient care going forward. 
READ MORE >

World’s first leadless LBBAP procedures linked to ‘promising’ outcomes

Cardiologists are turning to leadless pacemakers more and more for cardiac pacing, but those devices have not previously been able to perform LBBAP. This new analysis includes new data on the world’s very first leadless LBBAP procedures. 

READ MORE >
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Share on Twitter Share on Facebook Share on Linkedin

World’s first leadless LBBAP procedures linked to ‘promising’ outcomes

Share on Twitter Share on Facebook Share on Linkedin
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Cardiologists are turning to leadless pacemakers more and more for cardiac pacing, but those devices have not previously been able to perform LBBAP. This new analysis includes new data on the world’s very first leadless LBBAP procedures. 
READ MORE >

Smaller LV dimensions may increase risk of death for HeartMate 3 LVAD patients

Researchers tracked short- and long-term data from nearly 2,000 patients, presenting their findings in JACC: Heart Failure. 

READ MORE >
Abbott’s HeartMate 3 left ventricular assist device (LVAD) has been implanted in thousands of U.S. patients in recent years.According to a new investigative report from CBS News and KFF Health News, however, safety data related to the device have raised questions in certain parts of the healthcare industry.
Share on Twitter Share on Facebook Share on Linkedin

Smaller LV dimensions may increase risk of death for HeartMate 3 LVAD patients

Share on Twitter Share on Facebook Share on Linkedin
Abbott’s HeartMate 3 left ventricular assist device (LVAD) has been implanted in thousands of U.S. patients in recent years.According to a new investigative report from CBS News and KFF Health News, however, safety data related to the device have raised questions in certain parts of the healthcare industry.
Researchers tracked short- and long-term data from nearly 2,000 patients, presenting their findings in JACC: Heart Failure. 
READ MORE >

In Other News

FDA clears cardiac CT scanner for low-dose lung cancer screening

The scanner can complete two life-saving imaging acquisitions with a single pass.

READ MORE >
CT scanner screens for cardiovascular disease and lung cancer with single image.
Share on Twitter Share on Facebook Share on Linkedin

FDA clears cardiac CT scanner for low-dose lung cancer screening

Share on Twitter Share on Facebook Share on Linkedin
CT scanner screens for cardiovascular disease and lung cancer with single image.
The scanner can complete two life-saving imaging acquisitions with a single pass.
READ MORE >

Small pharmacies stockpile drugs as tariff fears grow

KFF Health News interviewed multiple independent pharmacies for a new report, detailing their basements full of generic and specialty drugs as a hedge against supply shocks. 

READ MORE >
artificial intelligence pharmaceutical industry
Share on Twitter Share on Facebook Share on Linkedin

Small pharmacies stockpile drugs as tariff fears grow

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence pharmaceutical industry
KFF Health News interviewed multiple independent pharmacies for a new report, detailing their basements full of generic and specialty drugs as a hedge against supply shocks. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Star Trek star's family awarded $13M | AI for cardiac amyloidosis | TAVR concerns | New CKM syndrome guidelines
A brand new payment model | Cardiologist compensation keeps rising | Major medtech player invests $1.5B in TAVR tech
Death after TAVR: New data support a change | Rural hospital in spotlight for wrong reason | Heart changes linked to cancer risk
Physicians push back after government report | Device recalled | A lesson for PAD patients | AI for long-term stroke risk
The pros & cons of direct-to-patient drug programs | Why PAD patients should listen to their doctors
Coffee linked to major heart risk | Ablations in ASCs | Catheters recalled | A closer look at PFA | GLP-1 drugs & AFib
New guidelines for cardiovascular-kidney-metabolic syndrome and M-TEER | HF cell therapy company raises $4.4 million

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup